Scotiabank Maintains Sector Outperform on American Healthcare REIT, Lowers Price Target to $51
Benzinga Newsdesk 4 months ago
NewsPrice TargetAnalyst Ratings
Scotiabank analyst Nicholas Yulico maintains American Healthcare REIT (NYSE:AHR) with a Sector Outperform and lowers the price target from $59 to $51.
Scotiabank analyst Nicholas Yulico maintains American Healthcare REIT (NYSE:AHR) with a Sector Outperform and lowers the price target from $59 to $51.